BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17692054)

  • 1. Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex.
    Józwiak S; Domańska-Pakieła D; Kotulska K; Kaczorowska M
    Epilepsia; 2007 Aug; 48(8):1632; author reply 1632-4. PubMed ID: 17692054
    [No Abstract]   [Full Text] [Related]  

  • 2. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
    Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
    Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
    Yum MS; Lee EH; Ko TS
    J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile spasms in tuberous sclerosis complex: prognostic utility of EEG.
    Muzykewicz DA; Costello DJ; Halpern EF; Thiele EA
    Epilepsia; 2009 Feb; 50(2):290-6. PubMed ID: 18801034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing epilepsy in tuberous sclerosis complex.
    Thiele EA
    J Child Neurol; 2004 Sep; 19(9):680-6. PubMed ID: 15563014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of epilepsy in tuberous sclerosis complex.
    Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
    Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
    van der Poest Clement EA; Sahin M; Peters JM
    J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E; Osborne JP
    J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of the medical treatment of West syndrome.
    Verrotti A; Manco R; Coppola GG; Mingione S; Chiarelli F; Iannetti P
    Minerva Pediatr; 2007 Jun; 59(3):249-53. PubMed ID: 17519870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable prognostic factors with infantile spasms.
    Riikonen RS
    Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.
    Kotulska K; Kwiatkowski DJ; Curatolo P; Weschke B; Riney K; Jansen F; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Sijko K; Głowacka-Walas J; Borkowska J; Sadowski K; Domańska-Pakieła D; Moavero R; Hertzberg C; Hulshof H; Scholl T; Benova B; Aronica E; de Ridder J; Lagae L; Jóźwiak S;
    Ann Neurol; 2021 Feb; 89(2):304-314. PubMed ID: 33180985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis].
    Rotta NT; da Silva AR; Ohlweiler L; Riesgo R
    Arq Neuropsiquiatr; 2003 Dec; 61(4):988-90. PubMed ID: 14762603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
    Humphrey A; Neville BG; Clarke A; Bolton PF
    Dev Med Child Neurol; 2006 Jul; 48(7):609-11. PubMed ID: 16780633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: A Long-Term, Prospective Trial.
    Jozwiak S; Słowińska M; Borkowska J; Sadowski K; Łojszczyk B; Domańska-Pakieła D; Chmielewski D; Kaczorowska-Frontczak M; Głowacka J; Sijko K; Kotulska K
    Pediatr Neurol; 2019 Dec; 101():18-25. PubMed ID: 31481332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management for epilepsy in tuberous sclerosis complex.
    Curatolo P; Bombardieri R; Cerminara C
    Curr Opin Neurol; 2006 Apr; 19(2):119-23. PubMed ID: 16538083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.